abrdn plc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
abrdn plc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$36,000
-16.3%
11,2460.0%0.00%
Q2 2022$43,000
-29.5%
11,2460.0%0.00%
Q1 2022$61,000
-59.9%
11,2460.0%0.00%
Q4 2021$152,000
-24.8%
11,2460.0%0.00%
Q3 2021$202,000
+4.7%
11,2460.0%0.00%
Q2 2021$193,000
-14.2%
11,2460.0%0.00%
-100.0%
Q1 2021$225,000
+17.8%
11,2460.0%0.00%
Q4 2020$191,000
+2.7%
11,2460.0%0.00%
Q3 2020$186,000
-28.7%
11,2460.0%0.00%
-100.0%
Q2 2020$261,000
+29.9%
11,2460.0%0.00%0.0%
Q1 2020$201,000
-17.3%
11,2460.0%0.00%0.0%
Q4 2019$243,000
-79.9%
11,246
-83.1%
0.00%
-66.7%
Q3 2019$1,210,000
-77.4%
66,434
-55.8%
0.00%
-75.0%
Q2 2019$5,354,000
-25.6%
150,381
-29.8%
0.01%
-25.0%
Q1 2019$7,198,000
-3.3%
214,121
-4.6%
0.02%
-11.1%
Q4 2018$7,444,000
-24.6%
224,415
+38.5%
0.02%0.0%
Q3 2018$9,876,000
+312.9%
162,011
+230.8%
0.02%
+260.0%
Q2 2018$2,392,000
-43.4%
48,982
+23.1%
0.01%
-37.5%
Q1 2018$4,229,000
+396.9%
39,805
+179.4%
0.01%
+300.0%
Q4 2017$851,000
+66.9%
14,246
-32.9%
0.00%
+100.0%
Q3 2017$510,00021,2460.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders